Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > INVESTORS ARENT BUYING IT YET

<< Previous

Bullboard Posts

Next >>

Comment by Gooseybearon Aug 25, 2024 11:25am

136 Views

Post# 36195201

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:INVESTORS ARENT BUYING IT YET

I can only respond as to my personal experience with NIMBC since 2017 currently in remission. Thank God. I'm not familiar with a Keytruda BCG compound. I've only been through 20 BCG treatments as Keytruda has significant side effects according to my Urologist as BCG is currently his standard of care. It's my understanding that Keytruda is only used for advanced stages of bladder cancer due to its potential side effects.

<< Previous

Bullboard Posts

Next >>

Here are three global stocks you should watch